Nurix Therapeutics, Inc. NRIX Deferred Tax Liabilities
Deferred Tax Liabilities at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilities.
The official record: Nurix Therapeutics, Inc.’s 10-K, filed January 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s deferred tax liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s deferred tax liabilities?
- Nurix Therapeutics, Inc. (NRIX) reported deferred tax liabilities of $14.43M in Q3 2025.
- What does deferred tax liabilities mean?
- Future tax obligations from temporary differences — most commonly accelerated tax depreciation that creates higher current tax deductions than book depreciation.